Auscura · Clinical platform

Six minutes per patient.
Auscura gives you four of them back.

An OPD doctor in a busy clinic sees fifty patients before lunch. Auscura sits across the whole visit: it listens and structures the history, works out the drug options with the evidence attached, and then keeps asking the patient how they’re doing three weeks later, when everyone else has moved on.

Request a clinic pilot

What actually happens in an OPD

A patient walks in with a plastic bag. Inside it: two lab reports, a discharge summary from a hospital eighteen months ago, and a strip of tablets with the foil cut so the name is half gone. She has six minutes. The doctor writes on a pad, in handwriting the pharmacist will interpret creatively, and by the time she reaches the counter the brand has been substituted for whatever the shop stocks.

She was prescribed a three-month course. She stops in week two because the monthly cost was ₹1,400 and nobody asked her what she could afford. The doctor never finds out. He has no mechanism to find out, and forty more patients waiting.

There are five thousand brands of the same handful of molecules on the Indian market. No clinician can hold the price spread in their head, and the person who most reliably tells them what to prescribe is the medical rep who came by on Tuesday. That is the market Auscura is built for.

Three modules, one visit

Diagnosis, prescription, follow-up. Most tools pick one and leave the seams to you.

Module A · Diagnosis support

Consent first. Then Auscura listens to the consultation, reads whatever the patient brought with them, and hands back a structured picture instead of a wall of transcript.

Module B · Prescription intelligence

Search by brand or by molecule. See monotherapy against combination options, filtered for what the patient can tolerate and what they can afford, with the journal or guideline behind every option.

Module C · Follow-up that actually happens

Structured check-ins over WhatsApp or the app, timed to the drug rather than to the calendar. The answers come back to the doctor, not into a void.

The history is already being spoken. Nobody is capturing it.

Consent is the gate. Nothing records until the patient has said yes, in their own language, and the consent is timestamped and stored against the encounter. Withdrawal deletes the audio.
Voice capture of the dialogue. The consultation happens in Hindi, or Marathi, or code-switched English. Auscura handles the mix and produces a structured history.
Reports go in as they arrive. A photo of a lab printout taken at an angle in bad light. A PDF discharge summary. Auscura pulls the values, plots the trend, and flags what’s out of range against the patient’s own baseline.
What comes back. A one-screen summary, a differential the doctor can accept or throw away, red flags called out separately, and a short list of what is missing.
Every line is sourced. Tap any statement in the summary and it opens the moment in the transcript or the line in the report it came from.

Auscura proposes. The doctor decides. Always.

The differential is a prompt for thought, not an answer. It is presented as a ranked list with the reasoning shown, it can be dismissed in one tap, and the dismissal is logged. No diagnosis is recorded, no prescription is generated, and nothing reaches the patient until a registered clinician has reviewed and signed it. That constraint is enforced in the product, not in a policy document nobody reads.

Five thousand brands. One molecule. Nobody can hold that in their head.

Brand → molecule → options

Type the brand. Auscura resolves it to the exact formulation and its underlying molecule or molecules. Single-pill therapy where a fixed-dose combination exists. Multi-drug therapy where combination is clinically indicated, with the interaction check already run.

Molecule → every brand carrying it

Search the molecule and get every brand that contains it, with strength, composition, and the price band. The ₹1,400 option and the ₹190 option sit next to each other on the same screen.

Two filters that change the prescription

Patient-friendly: Ranks options by pill burden, dosing frequency, whether it can be taken with food, tolerability profile, and formulation. A once-daily single pill that gets taken beats a twice-daily pair that does not.

Pocket-friendly: Ranks by monthly cost of the full course, not per-strip price, with generic equivalents surfaced alongside. Cost is a clinical variable in most of the world.

Every option carries its source

Pick any drug and Auscura shows the full composition and, beside it, what recommends it: the guideline body and version, the journal, the trial. Not “evidence-based” as a marketing adjective. The actual citation, with the year, linked.

The prescription leaves the room and the loop never closes.

Ask a doctor what happened to the patient they started on a new antihypertensive six weeks ago and you will usually get an honest shrug. Not through indifference. There is simply no channel.

On WhatsApp, because that is where the patient already is. No download, no login, no app the patient opens once and deletes.
Timed to the drug, not to the calendar. A check-in at day three for the antibiotic, day fourteen for the SSRI, day thirty for the statin.
Questions a person can answer in a moving auto-rickshaw. Are you still taking it. Is the pain better, worse, the same. Short, structured, tap-to-answer, in the patient’s language.
Adherence is measured, not assumed. If the answers stop, that is a signal.
Red flags escalate immediately. A reported symptom that matches a serious adverse reaction pattern goes to the clinician on the same day.
It comes back as a worklist. Not a dashboard the doctor is supposed to remember to open. A short ranked list of the patients who need something.

Safety, privacy, and the things we won’t do

A licensed clinician signs everything. No diagnosis, prescription, referral, or patient message leaves Auscura unreviewed. Enforced in code.
Auscura does not treat and does not triage autonomously. There is no mode, no setting, and no enterprise tier in which it does.
Consent is revocable and the revocation is real. Withdrawal deletes the audio and stops future contact.
Bias monitoring across cohorts. Differential quality and prescription recommendations measured by age, sex, language, and socioeconomic proxy.
Your patient data does not train foundation models without a separate agreement you can revoke.
Continuous clinical review. Output quality benchmarked against clinician-adjudicated gold standards.

Who it’s for

High-volume OPD and outpatient clinics where the constraint is minutes per patient, not access to information.
Single-specialty chains — cardiology, diabetology, psychiatry — where the same molecules recur and the follow-up window is well defined.
Multi-location hospital groups wanting prescribing consistency across sites.
Individual practitioners who want the molecule search and the follow-up loop and none of the enterprise apparatus.

Start with one clinic and one specialty.

We’ll baseline consultation time, prescription cost, and follow-up response before we start, and we will show you the numbers afterwards whether they flatter us or not.